Tag: upstream bioprocessing market analysis

  • Global Upstream Bioprocessing Market Forecast 2024-2033: Estimated Market Size And Growth Rate

    Global Upstream Bioprocessing Market Forecast 2024-2033: Estimated Market Size And Growth Rate

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Upstream Bioprocessing Market from 2024 to 2033?
    The upstream bioprocessing market is forecasted to grow from $10.63 billion in 2023 to $12.03 billion in 2024, at a CAGR of 13.1%. This growth is linked to the need for process optimization, safe and efficient biomolecule production, demand for biotherapeutics, the implementation of process analytical technology, chronic disease prevalence, and research into biosimilars.

    The upstream bioprocessing market is expected to see rapid growth, projected to reach $19.84 billion by 2028 at a CAGR of 13.3%. Growth factors include the commercial use of single-use bioreactors, outsourcing in biopharmaceutical manufacturing, rapid growth in pharmaceutical and biotech industries, rising adoption of single-use technologies, and increased collaborations and mergers. Key trends include higher R&D investment in biopharmaceuticals, technological advancements, and development of new filtration technologies.

    Claim Your Free Sample of the Global Upstream Bioprocessing Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15950&type=smp

    What Key Factors Are Fueling the Growth of the Upstream Bioprocessing Market?
    The outsourcing of biopharmaceutical manufacturing is anticipated to boost the upstream bioprocessing market. This involves delegating parts of production to external entities, enhancing efficiency and reducing costs. For instance, BDO USA estimates that by 2025, contract manufacturing organizations will control 44% of the global mammalian capacity. Thus, outsourcing biopharmaceutical manufacturing is driving the growth of this market.

    What Are the Major Segments of the Upstream Bioprocessing Market?
    1) By Product type: Bioreactors, Fermenters, Cell Culture Media, Filters, Bags And Containers
    2) By Workflow: Media Preparation, Cell Culture, Cell Separation
    3) By Usage type: Single-Use, Multi-Use
    4) By Mode: In House, Outsourced
    5) By End User: Contract Development and Manufacturing Organization (CDMOs) Or Contract Research Organization (CROs), Research And Academic Institutes, Biopharmaceutical Companies

    What New Trends Are Transforming the Upstream Bioprocessing Market?
    In the upstream bioprocessing market, advanced bioreactors are being developed to enhance cell culture processes. In April 2023, Cytiva introduced X-platform bioreactors designed for efficient single-use bioprocessing, featuring a modular design and user-friendly elements to facilitate scale-up.

    Order Now for Fast Delivery of Your Upstream Bioprocessing Market Report!
    https://www.thebusinessresearchcompany.com/report/upstream-bioprocessing-global-market-report

    Which Regions Are Driving Growth in the Upstream Bioprocessing Market?
    North America was the largest region in the upstream bioprocessing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the upstream bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    The Upstream Bioprocessing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the upstream bioprocessing market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Upstream Bioprocessing Market Include

    1. Upstream Bioprocessing Market Executive Summary
    2. Upstream Bioprocessing Market Segments
    3. Upstream Bioprocessing Market Size And Template Market Growth Rate
    4.  Key Upstream Bioprocessing Market Trends
    5. Major Upstream Bioprocessing Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Upstream Bioprocessing Market
    26. Top Upstream Bioprocessing Companies
    27. Upstream Bioprocessing Market Opportunities And Strategies
    28. Upstream Bioprocessing Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Single Use Bioprocessing Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/single-use-bioprocessing-global-market-report

    Single Use Bioprocessing Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/single-use-bioprocessing-global-market-report

    Streaming Analytics Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/streaming-analytics-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Upstream Bioprocessing Market 2024

    5 Key Insights On The Upstream Bioprocessing Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Upstream Bioprocessing Global Market Report 2024, the upstream bioprocessing market is expected to show significant growth in the forecast period.

    The upstream bioprocessing market has experienced impressive growth in recent years and is poised for further expansion. This blog explores the factors driving this growth, the impact of outsourcing, advancements in technology, and the future outlook of the industry.

    Market Growth Overview

    • Current and Projected Market Size
      • The market size surged from $10.63 billion in 2023 to $12.03 billion in 2024.
      • The compound annual growth rate (CAGR) for this period is 13.1%.
      • Projected growth will see the market reach $19.84 billion by 2028 with a CAGR of 13.3%.
    • Historical Growth Drivers
      • Increased need for process optimization and contamination-free production.
      • Rising demand for bio-therapeutics and biosimilars.
      • Growing prevalence of chronic diseases and implementation of process analytical technology.

    View More On The Upstream Bioprocessing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/upstream-bioprocessing-global-market-report

    Outsourcing: A Key Growth Catalyst

    • Impact on Market Expansion
      • Outsourcing biopharmaceutical manufacturing to contract organizations is accelerating growth.
      • Benefits include cost efficiency, access to specialized expertise, and flexibility in production.
    • Industry Statistics
      • By 2025, contract development and manufacturing organizations (CDMOs) are expected to control 44% of global mammalian capacity.

    Advanced Bioreactors: Enhancing Efficiency and Scalability

    • Technological Advancements
      • Companies are focusing on developing advanced bioreactors to improve cell culture processes.
      • Notable example: Cytiva’s X-platform bioreactors introduced in April 2023, designed for flexible, single-use upstream bioprocessing.
    • Features and Benefits
      • Modular design with user-friendly features such as optimized vessels and improved cable management.
      • Online Bioreactor Scaler tool for successful scale-up.

    Licensing and Innovation

    • Lonza and Adva Biotechnology Partnership
      • In May 2022, Lonza granted Adva Biotechnology a license for smart automation and bioreactor patents.
      • This agreement supports Adva’s global expansion in automated bioreactors.
    • Strategic Importance
      • The partnership highlights the trend towards innovative upstream bioprocessing technologies.

    Market Segmentation

    • By Product Type
      • Bioreactors, fermenters, cell culture media, filters, bags, and containers.
    • By Workflow
      • Media preparation, cell culture, cell separation.
    • By Usage Type
      • Single-use and multi-use.
    • By Mode
      • In-house and outsourced.
    • By End User
      • CDMOs, research and academic institutes, and biopharmaceutical companies.

    Regional Insights

    • Current Trends
      • North America was the largest region in 2023.
    • Future Projections
      • Asia-Pacific is anticipated to be the fastest-growing region in the forecast period.

    The upstream bioprocessing market is evolving rapidly, driven by technological advancements, increased outsourcing, and strategic partnerships. As the industry continues to grow, these trends and innovations will play a critical role in shaping its future trajectory.

    Request A Sample Of The Global Upstream Bioprocessing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15950&type=smp